OSAKA -- Ono Pharmaceutical has redeployed a significant portion of its sales force to the cancer battlefront to promote a new cancer immunity drug.
Business
OSAKA -- Ono Pharmaceutical has redeployed a significant portion of its sales force to the cancer battlefront to promote a new cancer immunity drug.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.